Byung H. Son
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 169 publications
Clinical Benefit of Adjuvant Capecitabine According To Residual Cancer Burden in Patients With Triple-Negative Breast Cancer With Residual Disease Following Neoadjuvant Chemotherapy.
Journal: Clinical breast cancer
Published: May 22, 2025
PIBF1 expression and survival outcome in TNBC and Non-TNBC breast cancer patients with lymph node metastasis who undertaken chemotherapy.
Journal: Scientific reports
Published: June 18, 2024
Comparison of long-term oncological outcomes after central lumpectomy versus nipple-sparing breast-conserving surgery for centrally located breast cancer: a propensity score-matched study.
Journal: Breast cancer research and treatment
Published: October 17, 2023
21-gene expression assay and clinical outcomes of premenopausal patients with hormone receptor-positive breast cancer.
Journal: International journal of cancer
Published: April 03, 2023
Breast Cancer Recurrence after Smooth versus Textured Implant-Based Breast Reconstruction: A Matched Cohort Study.
Journal: Plastic and reconstructive surgery
Published: August 09, 2022
Clinicopathological characteristics and outcomes of malignant adenomyoepithelioma of the breast: a single institution's experience.
Journal: World journal of surgical oncology
Published: November 11, 2021
Oncologic outcomes of immediate breast reconstruction in young women with breast cancer receiving neoadjuvant chemotherapy.
Journal: Breast cancer research and treatment
Published: June 29, 2021
Breast cancer outcomes following immediate breast reconstruction with implants versus autologous flaps: a propensity score-matched study.
Journal: Breast cancer research and treatment
Published: April 05, 2021
Factors Predicting Locoregional Recurrence After Neoadjuvant Chemotherapy and Nipple-Sparing/Skin-Sparing Mastectomy With Immediate Breast Reconstruction.
Journal: Frontiers in oncology
Published: March 04, 2021
Effectiveness of a 6-Month 22.5-mg Leuprolide Acetate Depot Formulation With Tamoxifen for Postoperative Premenopausal Estrogen Suppression in Hormone Receptor-Positive Breast Cancer.
Journal: Frontiers in oncology
Published: February 08, 2021
Last Updated: 09/26/2026